Current position: Home > Database > Screening compo...

Screening Compound Database

Core database: It contains over 30,000 active compound structures and about 1.6 million drug class screening compounds, with advantages such as diverse structural composition, good compound diversity, good drug class properties, and high cost performance. Using this database can find high-quality, cost-effective compounds within a suitable screening range, reduce the cost of initial research, and colleagues meet the core screening needs of drug function repositioning and virtual screening.

Brand Number	Quantity	Characteristic
T001	36,861	The advantageous products are known active compounds and natural products, with high product quality, good service attitude, and high cost performance.
D001	1,583,358	One of the world's largest compound brands, with over 5000 compound skeleton structures and over 100 compound libraries, is cost-effective.

Selected database: Contains data on screening compounds for a total of 7.06 million categories of drugs from 8 brands. Virtual screening has the ability to quickly screen a large number of compounds, which often requires a larger amount of data. This database adds a large number of compound structures to the core database, providing scientists with more screening possibilities. Suitable for users who require a large amount of structured data and have sufficient funding.

Brand Number	Quantity	Characteristic
D006	1,562,423	A compound brand originating in the United States, headquartered in San Diego, with a variety of popular compound libraries such as diversity library and macrocyclic library.
D011	522,326	A compound brand originating in Canada, with more than 2900 compound skeleton structures, complete compound specifications, and corresponding prices.
D008	204,354	A compound brand originating in the Netherlands has a significant price advantage.
D009	1,409,339	A compound brand originating in the United States, with a shipping center in Hong Kong, fast delivery speed, and moderate prices.
D019	44,193	A natural product brand originating in Germany, specializing in natural product extraction and synthesis of analogues, with stable product quality and relatively expensive prices.
D003	2,786,319	A compound brand originating in Ukraine, with strong research and development capabilities, has two types of products: cost-effective compounds and high-value compounds.
D010	486,062	A compound brand originating in Russia, with a variety of natural products and derivatives at a relatively high price.
D012	53,352	A compound brand originating in the UK, with a small and specialized product quantity and a large inventory of each product.

Extended database: Contains data on 9 brands and 3.69 million drug screening compounds. For virtual screening with sufficient computational power, it is always difficult to meet the demand for the number of structures of available solid compounds. The database has expanded and collected more data on the basis of the aforementioned data, making the database contain a richer variety of structural types.

Brand Number	Quantity	Characteristic
D020	276,701	A British brand with over 20 years of experience in organic synthesis.
D058	202,420	A compound brand originating in Russia, specializing in the production and sales of new screening compounds.
D104	26,848	A compound brand originating in Russia, with over 20 years of compound supply experience, sufficient inventory, and high cost performance.
D065	575,302	A brand originating in the United States, dedicated to the research and development and supply of lead like compounds and molecular blocks for more than 20 years, with relatively high prices.
D015	686,903	A young and rapidly growing compound brand originating in Ukraine, the product is mainly used for high throughput screening and drug discovery, with high prices.
D059	61,009	A compound brand originating in Ukraine, which has been committed to providing high throughput screening compounds and related services for nearly 20 years, has a price advantage.
D063	52,640	A compound brand originating in Germany, dedicated to developing unique compounds for pharmaceutical, agricultural, and biotechnology companies.
D021	1,532,542	A compound brand originating in the United States that has designed unique small molecule compounds for drug development for more than 20 years.
D013	277,932	A Canadian compound brand specializing in the development and production of specialty compounds, biochemical drugs, and bioanalytical reagents.